8-K: Current report filing
Published on March 31, 2009
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported)
March
31, 2009
NEOGENOMICS,
INC.
(Exact
name of registrant as specified in its charter)
|
Nevada
|
333-72097
|
74-2897368
|
|
(State
or other jurisdiction of
|
(Commission
File Number)
|
(I.R.S.
Employer
|
|
incorporation)
|
Identification
No.)
|
|
|
12701 Commonwealth Drive, Suite 9, Fort Myers,
Florida
(Address
of principal executive offices)
|
33913
(Zip
Code)
|
(239)
768-0600
(Registrant’s
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
□
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
□
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
□
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
□
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
|
Results
of Operations and Financial
Condition.
|
The
unaudited consolidated balance sheet of NeoGenomics, Inc. (the “Company”) as of
December 31, 2008 and December 31, 2007, the unaudited consolidated statements
of operations of the Company for the three and twelve months ended December 31,
2008 and December 31, 2007 and the unaudited consolidated statements of cash
flows of the Company for the twelve months ended December 31, 2008 and December
31, 2007 are furnished with this Current Report on Form 8-K as Exhibit
99.1.
This
information shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to the liabilities of that section, and it shall not be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific
reference in such filing.
|
Item
9.01.
|
Financial
Statements and Exhibits.
|
|
|
(a)
|
Not
applicable
|
|
|
(b)
|
Not
applicable
|
|
|
(c)
|
Not
applicable
|
|
|
(d)
|
Exhibits.
|
|
|
99.1
|
The
unaudited consolidated balance sheet of the Company as of December 31,
2008 and December 31, 2007, the unaudited consolidated statements of
operations of the Company for the three and twelve months ended December
31, 2008 and December 31, 2007 and the unaudited consolidated statements
of cash flows of the Company for the twelve months ended December 31, 2008
and December 31, 2007
|
-2-
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
NEOGENOMICS,
INC.
By: /s/Jerome J. Dvonch
Jerome J. Dvonch
Principal Accounting Officer
Jerome J. Dvonch
Principal Accounting Officer
Date:
March 31, 2009
-3-
Exhibit
Index
|
Exhibit No.
|
Description
|
|
|
99.1
|
The
unaudited consolidated balance sheet of the Company as of December 31,
2008 and December 31, 2007, the unaudited consolidated statements of
operations of the Company for the three and twelve months ended December
31, 2008 and December 31, 2007 and the unaudited consolidated statements
of cash flows of the Company for the twelve months ended December 31, 2008
and December 31, 2007
|
-4-